127 related articles for article (PubMed ID: 20093829)
1. Modeling hepatitis C virus therapies combining drugs and lectin affinity plasmapheresis.
Tullis RH; Duffin RP; Ichim TE; Joyce JA; Levin NW
Blood Purif; 2010; 29(2):210-5. PubMed ID: 20093829
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of double filtration plasmapheresis with pegylated interferon/ribavirin therapy for intractable chronic hepatitis C patients and hepatitis C patients with combined liver cirrhosis by HBV, leading to early viral elimination.
Ohara T; Oteki T; Suzuki T; Suzuki M; Matsuzaki Y
Hepatogastroenterology; 2011; 58(105):133-6. PubMed ID: 21510300
[TBL] [Abstract][Full Text] [Related]
3. Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy.
Ishikawa T; Higuchi K; Kubota T; Seki K; Honma T; Yoshida T; Kamimura T; Tasaki K; Hirose S; Suzuki Y
Ther Apher Dial; 2011 Aug; 15(4):400-5. PubMed ID: 21884476
[TBL] [Abstract][Full Text] [Related]
4. Double-Filtration Plasmapheresis plus Interferon-β for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy.
Kim SR; Saito J; Imoto S; Komaki T; Nagata Y; Kim KI; Sasase N; Kimura N; Sasatani K; Konishi E; Hasegawa Y; Fujinami A; Ohta M; El-Shamy A; Tanaka Y; Sugano M; Sakashita M; Nakamura A; Tsuchida S; Makino T; Kawada T; Nakajima T; Morikawa T; Muramatsu A; Kasugai H; Hotta H; Kudo M
Digestion; 2011; 84 Suppl 1():10-6. PubMed ID: 22156480
[TBL] [Abstract][Full Text] [Related]
5. [Prediction of sustained viral response to combinational therapy with interferon and ribavirin in chronic hepatitis C by rapid viral response].
Li MH; Chen LJ; Qiu GH; Lu Y; Xie Y; Xu DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):497-500. PubMed ID: 19912682
[TBL] [Abstract][Full Text] [Related]
6. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
[TBL] [Abstract][Full Text] [Related]
7. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
8. Double-filtration plasmapheresis plus IFN for HCV-1b patients with non-sustained virological response to previous combination therapy: early viral dynamics.
Kim SR; Imoto S; Kudo M; Mita K; Taniguchi M; Kim KI; Sasase N; Shoji I; Nagano-Fujii M; El-Shamy A; Hotta H; Nagai T; Nagata Y; Hayashi Y
Intervirology; 2010; 53(1):44-8. PubMed ID: 20068340
[TBL] [Abstract][Full Text] [Related]
9. Double filtration plasmapheresis could induce a favorable immune response for chronic hepatitis C therapy.
Kondo Y; Ueno Y; Shimosegawa T
Ther Apher Dial; 2012 Oct; 16(5):478-9. PubMed ID: 23046374
[No Abstract] [Full Text] [Related]
10. [Treatment of hepatitis C virus infection].
Zeuzem S
Praxis (Bern 1994); 2005 May; 94(18):721-6. PubMed ID: 15938383
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis C in southern Taiwan.
Chuang WL; Yu ML; Dai CY; Chang WY
Intervirology; 2006; 49(1-2):99-106. PubMed ID: 16166797
[TBL] [Abstract][Full Text] [Related]
12. Prolonged PEG-IFN and RBV is effective in patients with HCV genotype 1 and high viral load who achieved virological response later than 24 weeks.
Ueda T; Chung H; Kudo M; Ishikawa E; Hayaishi S; Tatsumi C; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
Intervirology; 2010; 53(1):55-9. PubMed ID: 20068342
[TBL] [Abstract][Full Text] [Related]
13. A case of chronic hepatitis C with nephrotic diabetic nephropathy who achieved sustained viral remission by double-filtration plasmapheresis and interferon combination therapy.
Okuyama H; Kimura S; Fujimoto K; Imura J; Chikazawa Y; Nakagawa M; Yamaya H; Yokoyama H
Intern Med; 2012; 51(15):1991-5. PubMed ID: 22864124
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study.
Milazzo L; Caramma I; Mazzali C; Cesari M; Olivetti M; Galli M; Antinori S
J Antimicrob Chemother; 2010 Apr; 65(4):735-40. PubMed ID: 20118492
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics].
Husa P; Slesinger P; Stroblová H; Svobodník A; Husová L
Klin Mikrobiol Infekc Lek; 2008 Apr; 14(2):67-73. PubMed ID: 18756436
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5.
Antaki N; Hermes A; Hadad M; Ftayeh M; Antaki F; Abdo N; Kebbewar K
J Viral Hepat; 2008 May; 15(5):383-6. PubMed ID: 18086180
[TBL] [Abstract][Full Text] [Related]
17. Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.
Derbala MF; El Dweik NZ; Al Kaabi SR; Al-Marri AD; Pasic F; Bener AB; Shebl FM; Amer AM; Butt MT; Yakoob R; John A; Al Mohanadi M; Al Khinji MA
J Viral Hepat; 2008 Aug; 15(8):591-9. PubMed ID: 18482284
[TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.
Kim SR; Imoto S; Mita K; Taniguchi M; Sasase N; Muramatsu A; Kudo M; Kitai S; El-Shamy A; Hotta H; Hayashi Y
Digestion; 2009; 79(1):36-9. PubMed ID: 19246919
[TBL] [Abstract][Full Text] [Related]
19. Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.
El Makhzangy H; Esmat G; Said M; Elraziky M; Shouman S; Refai R; Rekacewicz C; Gad RR; Vignier N; Abdel-Hamid M; Zalata K; Bedossa P; Pol S; Fontanet A; Mohamed MK
J Med Virol; 2009 Sep; 81(9):1576-83. PubMed ID: 19626613
[TBL] [Abstract][Full Text] [Related]
20. Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.
Escudero A; Rodríguez F; Serra MA; Del Olmo JA; Montes F; Rodrigo JM
J Gastroenterol Hepatol; 2008 Jun; 23(6):861-6. PubMed ID: 18422960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
